AU2003243563A1 - Markers of blood barrier permeability and methods of using same - Google Patents

Markers of blood barrier permeability and methods of using same

Info

Publication number
AU2003243563A1
AU2003243563A1 AU2003243563A AU2003243563A AU2003243563A1 AU 2003243563 A1 AU2003243563 A1 AU 2003243563A1 AU 2003243563 A AU2003243563 A AU 2003243563A AU 2003243563 A AU2003243563 A AU 2003243563A AU 2003243563 A1 AU2003243563 A1 AU 2003243563A1
Authority
AU
Australia
Prior art keywords
markers
methods
same
barrier permeability
blood barrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003243563A
Inventor
Nicola Marchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cleveland Clinic Foundation
Original Assignee
Cleveland Clinic Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cleveland Clinic Foundation filed Critical Cleveland Clinic Foundation
Publication of AU2003243563A1 publication Critical patent/AU2003243563A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Neurosurgery (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Neurology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2003243563A 2002-06-12 2003-06-12 Markers of blood barrier permeability and methods of using same Abandoned AU2003243563A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38837102P 2002-06-12 2002-06-12
PCT/US2003/018780 WO2004078204A1 (en) 2002-06-12 2003-06-12 Markers of blood barrier permeability and methods of using same

Publications (1)

Publication Number Publication Date
AU2003243563A1 true AU2003243563A1 (en) 2004-09-28

Family

ID=32962110

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003243563A Abandoned AU2003243563A1 (en) 2002-06-12 2003-06-12 Markers of blood barrier permeability and methods of using same

Country Status (3)

Country Link
EP (1) EP1551450A4 (en)
AU (1) AU2003243563A1 (en)
WO (1) WO2004078204A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1519194A1 (en) 2003-09-24 2005-03-30 Roche Diagnostics GmbH Use of gfap for identification of intracerebral hemorrhage
US8492107B2 (en) 2004-04-15 2013-07-23 University Of Florida Research Foundation, Inc. Neural proteins as biomarkers for nervous system injury and other neural disorders
CA2733990C (en) 2008-08-11 2018-12-11 Banyan Biomarkers, Inc. Biomarker detection process and assay of neurological condition
WO2010030203A1 (en) * 2008-09-09 2010-03-18 Biocodex - Incubação De Empresas De Ciências Da Vida, S.A. Monoclonal antibody to human amyloidogenic and modified forms of transthyretin and its use in the detection and treatment of fap and pathologies presenting modified ttr
US20130022982A1 (en) 2009-09-14 2013-01-24 Kevin Ka-Wang Wang Micro-rna, autoantibody and protein markers for diagnosis of neuronal injury

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6268223B1 (en) * 1999-08-27 2001-07-31 Viatech Imagin, Llc Assay for detecting damage to the central nervous system

Also Published As

Publication number Publication date
EP1551450A4 (en) 2005-11-23
EP1551450A1 (en) 2005-07-13
WO2004078204A1 (en) 2004-09-16

Similar Documents

Publication Publication Date Title
AU2003217870A1 (en) Pini-modulating compounds and methods of use thereof
AU2003225669A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003225668A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003213673A1 (en) Pin1-modulating compounds and methods of use thereof
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2003235676A1 (en) Tricyclic-bis-enone derivatives and methods of use thereof
AU2002330943A1 (en) Immunomodulatory compounds and methods of use thereof
AU2003224532A1 (en) Method and system of retransmission
EP1587955A4 (en) Markers for differential diagnosis and methods of use thereof
AU2003268046A1 (en) Medical cutting devices and methods of use
AU2003260527A1 (en) Methods of positions and/or orienting nanostructures
AU2003299734A1 (en) Luminescent polymers and methods of use thereof
AU2003241347A1 (en) Medical catheter assembly and method of using the same
AU2003272434A1 (en) System and method of drilling and completion
AU2002314466A1 (en) Withasol and methods of use
AU2003263039A1 (en) Drainage devices and methods
AU2003903547A0 (en) Structures and methods of waterproofing same
AU2003282558A1 (en) Nanopellets and method of making nanopellets
AU2003285254A1 (en) Drilling fluid and methods of use thereof
AU2003265645A1 (en) System and method of characterizing vascular tissue
AU2002324965A1 (en) Artificial kidney and methods of using same
AU2003258927A1 (en) Method and system of positioning
AU2002337913A1 (en) Glycosulfopeptide inhibitors and methods of use thereof
AU2003267888A1 (en) Method and system of positioning
AU2003215244A1 (en) Complexes and methods of using same

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase